vs
Side-by-side financial comparison of AAR CORP (AIR) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
AAR CORP is the larger business by last-quarter revenue ($795.3M vs $346.4M, roughly 2.3× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 4.4%, a 23.7% gap on every dollar of revenue. On growth, AAR CORP posted the faster year-over-year revenue change (15.9% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $6.2M).
AAR Corp. is an American provider of aircraft maintenance services to commercial and government customers worldwide. The company is headquartered in Wood Dale, Illinois, a Chicago suburb. The company employs about 6,000 people, operating in about 30 different countries. John Holmes is the current CEO.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AIR vs HAE — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $795.3M | $346.4M |
| Net Profit | $34.6M | $97.3M |
| Gross Margin | 19.7% | 57.2% |
| Operating Margin | 6.0% | 36.1% |
| Net Margin | 4.4% | 28.1% |
| Revenue YoY | 15.9% | 4.8% |
| Net Profit YoY | 213.1% | — |
| EPS (diluted) | $0.90 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $346.4M | ||
| Q4 25 | $795.3M | $339.0M | ||
| Q3 25 | $739.6M | $327.3M | ||
| Q2 25 | — | $321.4M | ||
| Q1 25 | — | $330.6M | ||
| Q4 24 | — | $348.5M | ||
| Q3 24 | — | $345.5M | ||
| Q2 24 | — | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | $34.6M | $44.7M | ||
| Q3 25 | $34.4M | $38.7M | ||
| Q2 25 | — | $34.0M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | — | $33.8M | ||
| Q2 24 | — | $38.4M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | 19.7% | 59.7% | ||
| Q3 25 | 18.1% | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | — | 36.1% | ||
| Q4 25 | 6.0% | 19.9% | ||
| Q3 25 | 6.4% | 17.9% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | 21.6% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 11.8% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | 4.4% | 13.2% | ||
| Q3 25 | 4.7% | 11.8% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 9.8% | ||
| Q2 24 | — | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.90 | $0.95 | ||
| Q3 25 | $0.95 | $0.81 | ||
| Q2 25 | — | $0.70 | ||
| Q1 25 | — | $1.17 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | — | $0.66 | ||
| Q2 24 | — | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.6M | $245.4M |
| Total DebtLower is stronger | $952.7M | $1.2B |
| Stockholders' EquityBook value | $1.6B | $796.3M |
| Total Assets | $3.2B | $2.4B |
| Debt / EquityLower = less leverage | 0.61× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $75.6M | $363.4M | ||
| Q3 25 | $80.0M | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | — | $299.3M | ||
| Q2 24 | — | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $952.7M | $1.2B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $1.6B | $911.5M | ||
| Q3 25 | $1.2B | $849.2M | ||
| Q2 25 | — | $882.3M | ||
| Q1 25 | — | $820.8M | ||
| Q4 24 | — | $906.9M | ||
| Q3 24 | — | $878.9M | ||
| Q2 24 | — | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $3.2B | $2.5B | ||
| Q3 25 | $2.9B | $2.4B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 0.61× | 1.34× | ||
| Q3 25 | 0.82× | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.6M | $293.2M |
| Free Cash FlowOCF − Capex | $6.2M | $209.9M |
| FCF MarginFCF / Revenue | 0.8% | 60.6% |
| Capex IntensityCapex / Revenue | 0.9% | 9.5% |
| Cash ConversionOCF / Net Profit | 0.39× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $13.6M | $93.6M | ||
| Q3 25 | $-44.9M | $111.3M | ||
| Q2 25 | — | $17.4M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | — | $43.8M | ||
| Q3 24 | — | $48.8M | ||
| Q2 24 | — | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $6.2M | $87.2M | ||
| Q3 25 | $-53.6M | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | 0.8% | 25.7% | ||
| Q3 25 | -7.2% | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% |
| Q1 26 | — | 9.5% | ||
| Q4 25 | 0.9% | 1.9% | ||
| Q3 25 | 1.2% | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 0.39× | 2.09× | ||
| Q3 25 | -1.31× | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIR
| Commercial Customer | $268.1M | 34% |
| Repair And Engineering | $244.5M | 31% |
| Integrated Solutions | $175.8M | 22% |
| Government And Defense Customer | $85.5M | 11% |
| Expeditionary Services | $21.4M | 3% |
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
